1. Home
  2. OLMA vs CLMB Comparison

OLMA vs CLMB Comparison

Compare OLMA & CLMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • CLMB
  • Stock Information
  • Founded
  • OLMA 2006
  • CLMB 1982
  • Country
  • OLMA United States
  • CLMB United States
  • Employees
  • OLMA N/A
  • CLMB N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • CLMB Retail: Computer Software & Peripheral Equipment
  • Sector
  • OLMA Health Care
  • CLMB Technology
  • Exchange
  • OLMA Nasdaq
  • CLMB Nasdaq
  • Market Cap
  • OLMA 725.5M
  • CLMB 622.6M
  • IPO Year
  • OLMA 2020
  • CLMB N/A
  • Fundamental
  • Price
  • OLMA $8.48
  • CLMB $104.88
  • Analyst Decision
  • OLMA Strong Buy
  • CLMB Buy
  • Analyst Count
  • OLMA 6
  • CLMB 1
  • Target Price
  • OLMA $23.00
  • CLMB $136.00
  • AVG Volume (30 Days)
  • OLMA 969.7K
  • CLMB 38.9K
  • Earning Date
  • OLMA 11-10-2025
  • CLMB 10-29-2025
  • Dividend Yield
  • OLMA N/A
  • CLMB 0.66%
  • EPS Growth
  • OLMA N/A
  • CLMB 26.05
  • EPS
  • OLMA N/A
  • CLMB 4.64
  • Revenue
  • OLMA N/A
  • CLMB $620,431,000.00
  • Revenue This Year
  • OLMA N/A
  • CLMB $28.14
  • Revenue Next Year
  • OLMA N/A
  • CLMB $5.89
  • P/E Ratio
  • OLMA N/A
  • CLMB $22.27
  • Revenue Growth
  • OLMA N/A
  • CLMB 51.09
  • 52 Week Low
  • OLMA $2.86
  • CLMB $88.90
  • 52 Week High
  • OLMA $11.54
  • CLMB $145.02
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 49.32
  • CLMB 32.15
  • Support Level
  • OLMA $7.82
  • CLMB $105.45
  • Resistance Level
  • OLMA $8.80
  • CLMB $112.55
  • Average True Range (ATR)
  • OLMA 0.61
  • CLMB 5.88
  • MACD
  • OLMA -0.02
  • CLMB -0.88
  • Stochastic Oscillator
  • OLMA 41.57
  • CLMB 4.97

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

Share on Social Networks: